Clostridioides difficile is an anaerobic, spore-forming bacterium associated with intestinal
infection, manifesting a broad spectrum of gastrointestinal symptoms, ranging from mild …

Clostridioides difficile is the most common cause of nosocomial antibiotic-associated
diarrhoea and is responsible for a spectrum of diseases characterized by high levels of …

Probiotics are widely used as an adjuvant agent for the prevention of primary Clostridioides
difficile infection (pCDI) and are less commonly used in the treatment of pCDI. Here, the …

Probiotics have been widely used to prevent primary Clostridioides difficile infection (pCDI);
however, there are fewer studies on their therapeutic aspects for pCDI. In this study, high …

Clostridioides (C.) difficile is an important causative pathogen of nosocomial gastrointestinal
infections in humans with an increasing incidence, morbidity, and mortality. The available …

Clostridioides difficile infection (CDI) is responsible for an increasing number of cases of
post-antibiotic diarrhea worldwide, which has high severity and mortality among hospitalized …

The fraction of antibiotics that are excreted from the intestine during administration leads to
disruption of commensal bacteria as well as resulting in dysbiosis and various diseases. To …

Background Clostridioides difficile infections (CDI) and recurrence (rCDI) are major health
care burdens. Recurrence is likely caused by spores in the gastrointestinal tract that …

Clostridioides difficile is an enteric pathogen that can cause significant clinical disease in
both humans and animals. However, clinical disease arises most commonly after treatment …

Clostridioides difficile is a spore-forming enteric pathogen that causes life-threatening
diarrhea and colitis. Notably, C. difficile infection (CDI) is a major healthcare-associated …